Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | lamin dm0 | 0.002 | 0.0166 | 0.0166 |
Echinococcus multilocularis | musashi | 0.002 | 0.0166 | 0.0166 |
Schistosoma mansoni | tyrosyl-DNA phosphodiesterase | 0.005 | 0.0745 | 0.0745 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0855 | 0.0855 |
Echinococcus multilocularis | lamin | 0.002 | 0.0166 | 0.0166 |
Brugia malayi | MH2 domain containing protein | 0.009 | 0.1537 | 0.2426 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0163 | 0.298 | 1 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0519 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0333 | 0.6335 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0855 | 0.0855 |
Schistosoma mansoni | dihydrofolate reductase | 0.0047 | 0.0697 | 0.0697 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0855 | 0.1349 |
Echinococcus multilocularis | transcription factor Dp 1 | 0.0029 | 0.0333 | 0.0333 |
Brugia malayi | hypothetical protein | 0.0092 | 0.1583 | 0.2499 |
Loa Loa (eye worm) | hypothetical protein | 0.0333 | 0.6335 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.0855 | 0.1349 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0116 | 0.2049 | 1 |
Loa Loa (eye worm) | tyrosyl-DNA phosphodiesterase | 0.005 | 0.0745 | 0.1176 |
Brugia malayi | Tyrosyl-DNA phosphodiesterase family protein | 0.005 | 0.0745 | 0.1176 |
Schistosoma mansoni | mucolipin | 0.0049 | 0.0733 | 0.0733 |
Echinococcus granulosus | intermediate filament protein | 0.002 | 0.0166 | 0.0166 |
Brugia malayi | thymidylate synthase | 0.0116 | 0.2049 | 0.3234 |
Echinococcus granulosus | lamin | 0.002 | 0.0166 | 0.0166 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase, putative | 0.0055 | 0.0852 | 0.0479 |
Echinococcus multilocularis | dihydrofolate reductase | 0.0047 | 0.0697 | 0.0697 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0163 | 0.298 | 1 |
Echinococcus granulosus | lamin dm0 | 0.002 | 0.0166 | 0.0166 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0855 | 0.0855 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.0505 | 0.0798 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0038 | 0.0505 | 0.0798 |
Schistosoma mansoni | lamin | 0.002 | 0.0166 | 0.0166 |
Entamoeba histolytica | tyrosyl-DNA phosphodiesterase, putative | 0.005 | 0.0745 | 0.5 |
Schistosoma mansoni | mucolipin | 0.0045 | 0.0652 | 0.0652 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.009 | 0.1537 | 0.2426 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0163 | 0.298 | 0.5 |
Echinococcus multilocularis | tyrosyl DNA phosphodiesterase 1 | 0.005 | 0.0745 | 0.0745 |
Loa Loa (eye worm) | thymidylate synthase | 0.0116 | 0.2049 | 0.3234 |
Echinococcus granulosus | mucolipin 3 | 0.0049 | 0.0733 | 0.0733 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0163 | 0.298 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0855 | 0.0855 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0026 | 0.0271 | 0.0429 |
Echinococcus granulosus | tyrosyl DNA phosphodiesterase 1 | 0.005 | 0.0745 | 0.0745 |
Loa Loa (eye worm) | hypothetical protein | 0.0333 | 0.6335 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0092 | 0.1583 | 0.2499 |
Onchocerca volvulus | Huntingtin homolog | 0.0092 | 0.1583 | 0.2297 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0163 | 0.298 | 1 |
Onchocerca volvulus | 0.0116 | 0.2049 | 0.3052 | |
Loa Loa (eye worm) | mucolipin 1 | 0.0049 | 0.0733 | 0.1157 |
Echinococcus multilocularis | Protein lozenge | 0.0042 | 0.059 | 0.059 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0163 | 0.298 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0271 | 0.0429 |
Brugia malayi | hypothetical protein | 0.0055 | 0.0852 | 0.1345 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0038 | 0.0505 | 0.0798 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.0116 | 0.2049 | 1 |
Brugia malayi | Dihydrofolate reductase | 0.0047 | 0.0697 | 0.11 |
Loa Loa (eye worm) | hypothetical protein | 0.0092 | 0.1583 | 0.2499 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.0047 | 0.0697 | 0.11 |
Echinococcus multilocularis | thymidylate synthase | 0.0116 | 0.2049 | 0.2049 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0166 | 0.0262 |
Schistosoma mansoni | intermediate filament proteins | 0.002 | 0.0166 | 0.0166 |
Mycobacterium ulcerans | thymidylate synthase | 0.0116 | 0.2049 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0855 | 0.0855 |
Loa Loa (eye worm) | intermediate filament protein | 0.002 | 0.0166 | 0.0262 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0159 | 0.0251 |
Echinococcus multilocularis | mucolipin 3 | 0.0049 | 0.0733 | 0.0733 |
Echinococcus granulosus | transcription factor Dp 1 | 0.0029 | 0.0333 | 0.0333 |
Echinococcus granulosus | thymidylate synthase | 0.0116 | 0.2049 | 0.2049 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0038 | 0.0505 | 0.0798 |
Brugia malayi | intermediate filament protein | 0.002 | 0.0166 | 0.0262 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.002 | 0.0166 | 0.0262 |
Brugia malayi | dihydrofolate reductase family protein | 0.0047 | 0.0697 | 0.11 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0519 | 1 | 1 |
Schistosoma mansoni | lozenge | 0.0042 | 0.059 | 0.059 |
Echinococcus granulosus | dihydrofolate reductase | 0.0047 | 0.0697 | 0.0697 |
Onchocerca volvulus | 0.0333 | 0.6335 | 1 | |
Chlamydia trachomatis | dihydrofolate reductase | 0.0047 | 0.0697 | 0.5 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.002 | 0.0166 | 0.0262 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0055 | 0.0852 | 0.1148 |
Schistosoma mansoni | lamin | 0.002 | 0.0166 | 0.0166 |
Onchocerca volvulus | Huntingtin homolog | 0.0092 | 0.1583 | 0.2297 |
Loa Loa (eye worm) | runx1 | 0.0042 | 0.059 | 0.0931 |
Brugia malayi | Coelomocyte uptake defective protein 5 | 0.0049 | 0.0733 | 0.1157 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0855 | 0.0855 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0.0852 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.009 | 0.1537 | 0.2426 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0116 | 0.2049 | 0.2049 |
Schistosoma mansoni | hypothetical protein | 0.0026 | 0.0271 | 0.0271 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0855 | 0.0855 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 5.6234 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.